Significant Ownership of Cowen Financial Products LLC

Signature - Title
John Holmes - John Holmes / Chief Operating Officer
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Cowen Financial Products LLC.

Notify me when Cowen Financial Products LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Cowen Financial Products LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
XGN Exagen Inc. Common Stock, par value $0.001 per share 5% $5,214,491 891,366 Cowen Financial Products LLC 31 Mar 2025
TARS Tarsus Pharmaceuticals Inc. Common Stock, $0.0001 par value per share 4.9% $94,926,816 1,909,228 Cowen Financial Products LLC 31 Dec 2024
URGN UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share 0% $0 -$63,650,674 0 -100% Cowen Financial Products LLC 30 Sep 2025
STOK Stoke Therapeutics Inc Common Stock, $0.0001 par value per share 0% $0 -$74,571,563 0 -100% Cowen Financial Products LLC 30 Sep 2025
BRZH Breeze Holdings Acquisition Corp Common Stock, $0.0001 par value per share 0% 0 Cowen Financial Products LLC 31 Mar 2025

Schedules 13D/G Reported by Cowen Financial Products LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.